Listed Companies > Listed Companies Info. > General Stock Board Listed Companies > Listed Company Profile
General Stock Board Listed Company Profile
Code:
Industry:
Local/Foreign Company:
6497 ASLAN-KY
中文
Company Profile
Chairman CEO Spokesperson Tel Address Date of Listing (Regular)
Carl Firth Carl Firth Carl Firth 0227583333 35F, 68 ZhongXiao E. Rd Sec 5, XinYi Dist, Taipei City 110, TaiwanTaipei 11065, Taiwan 2017/06/01
Agent for litigious
and non-litigious matters
Tel of
Agent for litigious
and non-litigious matters
Address of
Agent for litigious
and non-litigious matters
Brandon Wei 0227583333 35F, 68 ZhongXiao E. Rd Sec 5, XinYi Dist, Taipei City 110, Taiwan
Industry Main Business
Biotechnology and Medical Care
亞獅康私人有限公司(ASLAN Pharmaceutical Pte. Ltd.)係依專注於腫瘤、開發免疫療法與標靶抗癌藥物之生物科技公司。
 
Market Information ( 2017/10/20 )
Shr. Vol. Highest Lowest Closed Change Transaction TurnOver(%) long
margin
balance
(1,000shr.)
Short
margin
balance
(1,000shr.)
246 42.00  40.95  41.10  -0.90  168 0.18 N/A N/A
Trading method Fun
purchase
price or
securities
pneeded
on T day
Announcement of Irregularity
(2017/10/22)
TPEx measures
adopted
(2017/10/22)
With warrants Can be shorted or margined? Detail
Normal N N N N N Today History
 
Financial Reports
Cash Flows Items
Amount
(NT$ thousand)
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Balance
Sheets
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Share capital
Capital surplus
Retained earnings
Other equity interest
Treasury shares
Total equity attributable to owners of parent
Non-controlling interests
Total equity
Book Value per share(NT$)
Comprehensive Income Operating revenue
Operating costs
Gross profit from operations
Operating expenses
Net other income (expenses)
Net operating income
Non-operating income and expenses
Profit before tax
Tax expense
Profit from continuing operations
Profit from discontinued operations
Profit
Other comprehensive income
Comprehensive income
Basic earnings per share
* Auditor's report on latest financial statements: auditor's report:
* More detail:MOPS
* Foreign issuers’ information is disclosed in consolidated statements.